Compounds > cabergoline
Page last updated: 2024-08-23

cabergoline and Depressive Disorder

cabergoline has been researched along with Depressive Disorder in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bettencourt-Silva, R; Carvalho, D; Pereira, J; Queirós, J1
Kulisevsky, J; Martinez-Corral, M; Pagonabarraga, J1
Bilal, L; Ching, C1
Csoka, AB; Shipko, S1

Other Studies

4 other study(ies) available for cabergoline and Depressive Disorder

ArticleYear
Giant prolactinoma, germline BRCA1 mutation, and depression: a case report.
    Journal of medical case reports, 2018, Dec-06, Volume: 12, Issue:1

    Topics: Adult; Antidepressive Agents; BRCA1 Protein; Cabergoline; Depressive Disorder; Dopamine Agonists; Female; Humans; Magnetic Resonance Imaging; Mutation; Pituitary Neoplasms; Prolactinoma

2018
Changes in artistic style and behaviour in Parkinson's disease: dopamine and creativity.
    Journal of neurology, 2009, Volume: 256, Issue:5

    Topics: Antiparkinson Agents; Arm; Art; Benzothiazoles; Brain; Cabergoline; Creativity; Depressive Disorder; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Motor Skills; Obsessive Behavior; Paintings; Parkinson Disease; Pramipexole

2009
Cabergoline-induced psychosis in a patient with undiagnosed depression.
    The Journal of neuropsychiatry and clinical neurosciences, 2012,Fall, Volume: 24, Issue:4

    Topics: Adult; Cabergoline; Depressive Disorder; Ergolines; Female; Humans; Pituitary Neoplasms; Prolactinoma; Psychoses, Substance-Induced

2012
Persistent sexual side effects after SSRI discontinuation.
    Psychotherapy and psychosomatics, 2006, Volume: 75, Issue:3

    Topics: Adult; Androgens; Anxiety; Bupropion; Cabergoline; Citalopram; Depressive Disorder; Dopamine Agonists; Dopamine Uptake Inhibitors; Ergolines; Female; Fluoxetine; Humans; Male; Monoamine Oxidase Inhibitors; Piperazines; Plants, Medicinal; Purines; Selective Serotonin Reuptake Inhibitors; Selegiline; Sertraline; Sexual Dysfunctions, Psychological; Sildenafil Citrate; Sleep Initiation and Maintenance Disorders; Sulfones; Testosterone; Time Factors; Treatment Outcome; Vasodilator Agents

2006